The Chondromimetic brand, founded in 2011 (United Kingdom), from 440 sister brands and 4958 competing brands. The Chondromimetic brand is owned by Takeda Pharmaceutical, a company listed in Francfort. Its International Securities Identification Number (ISIN) is JP3463000004. The sector of Chondromimetic is Drug Manufacturers.
Investment simulator :
Portfolio valuation
Takeda Pharmaceutical
(Chondromimetic)
over 5 years*
EUR 18.26